Exact Sciences Files for $125M Stock Offering | GenomeWeb

NEW YORK (GenomeWeb News) – Exact Sciences said after the close of the market Wednesday that it has launched a $125 million public offering of common stock.

The Madison, Wis.-based molecular diagnostics developer didn't say how many shares it intends to offer.

Its stock closed at $14.25 in Wednesday trade on the Nasdaq but was down around 5 percent at $13.49 Thursday morning.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: peanut subgenome progenitor sequence, homozygosity mapping and linkage analyses using exome data, and more.

Tech companies like Microsoft are looking into DNA as a data storage device, Scientific American writes.

The New York Times writes that the Max Planck Institute for Infection Biology's Emmanuelle Charpentier has always been on the move, though now it's more about CRISPR.

The European Union calls for all publicly funded scientific papers to be immediately freely accessible to the public by 2020.